Drug survival of interleukin 17 inhibitors after switch from interleukin 23 inhibitors in psoriasis: An observational cohort study

被引：0
|
作者：
Kushnir-Grinbaum, Daniella [1 ,2 ]
Ziv, Michael [1 ]
机构：
[1] Techn Inst Technol, Rappaport Fac Med, Emek Med Ctr, Dermatol Dept, Afula, Israel
[2] Sinclair Dermatol, East Melbourne, Vic, Australia
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 91卷 / 06期
关键词：
anti IL-17; anti IL-23; bio experienced; biologics; drug survival; guselkumab; IL-17; inhibitor; IL-23; interleukin-17;
D O I：
10.1016/j.jaad.2024.07.1514
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1260 / 1263
页数：4
相关论文
共 50 条
  • [21] Drug Survival of Anti Interleukin-17 and Interleukin-23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study
    Repetto, Federica
    Roccuzzo, Gabriele
    Burzi, Lorenza
    Mastorino, Luca
    Dapavo, Paolo
    Quaglino, Pietro
    Ribero, Simone
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [22] Effectiveness of brodalumab after previous treatment failure of interleukin-17A inhibitors in patients with psoriasis
    Loft, Nikolai
    Bregnhoj, Anne
    Fage, Simon
    Nielsen, Claus Henrik
    Enevold, Christian
    Zachariae, Claus
    Iversen, Lars
    Skov, Lone
    DERMATOLOGIC THERAPY, 2021, 34 (06)
  • [23] Effects of tumor necrosis factor-, interleukin-23 and interleukin-17A inhibitors on bodyweight and body mass index in patients with psoriasis
    Takamura, Saori
    Takahashi, Aya
    Inoue, Yumiko
    Teraki, Yuichi
    JOURNAL OF DERMATOLOGY, 2018, 45 (09): : 1130 - 1134
  • [24] Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis (vol 34, pg 39, 2020)
    Egeberg, A.
    Andersen, Y. M. F.
    Halling-Overgaard, A. -S.
    Alinaghi, F.
    Thyssen, J. P.
    Burge, R.
    Mallbris, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (09) : 2156 - 2156
  • [25] Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis - time for a paradigm change
    Nogueira, M.
    Warren, R. B.
    Torres, T.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (04) : 824 - 834
  • [26] Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With Psoriasis
    Green, Lawrence J.
    Yamauchi, Paul S.
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (08) : 776 - 788
  • [27] Efficacy of treatment with brodalumab after treatment failure of previous interleukin 17A inhibitors in patients with psoriasis
    Loft, Nikolai
    Bregnhoj, Anne
    Fage, Simon
    Nielsen, Claus Henrik
    Enevold, Christian
    Zachariae, Claus
    Iversen, Lars
    Skov, Lone
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB107 - AB107
  • [28] Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
    Torres, Tiago
    Puig, Luis
    Vender, Ron
    Lynde, Charles
    Piaserico, Stefano
    Carrascosa, Jose M.
    Gisondi, Paolo
    Dauden, Esteban
    Conrad, Curdin
    Mendes-Bastos, Pedro
    Ferreira, Paulo
    Leite, Luiz
    Lu, Justin D.
    Valerio, J.
    Bruni, M.
    Messina, F.
    Nidegger, A.
    Llamas-Velasco, M.
    del Alcazar, E.
    Mufti, A.
    White, Kyra
    Caldarola, G.
    Teixeira, Laetitia
    Romanelli, Paolo
    Desai, K.
    Gkalpakiotis, Spyridon
    Romanelli, Marco
    Yeung, Jensen
    Nogueira, Miguel
    Chiricozzi, Andrea
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 567 - 579
  • [29] The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: A systematic review
    Vangilbergen, Marie
    Stockman, Aline
    Van De Velde, Axelle
    Garmyn, Maria
    Punie, Kevin
    Hillary, Tom
    JAAD INTERNATIONAL, 2024, 17 : 71 - 79
  • [30] Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
    Tiago Torres
    Luis Puig
    Ron Vender
    Charles Lynde
    Stefano Piaserico
    Jose M. Carrascosa
    Paolo Gisondi
    Esteban Daudén
    Curdin Conrad
    Pedro Mendes-Bastos
    Paulo Ferreira
    Luiz Leite
    Justin D. Lu
    J. Valerio
    M. Bruni
    F. Messina
    A. Nidegger
    M. Llamas-Velasco
    E. del Alcazar
    A. Mufti
    Kyra White
    G. Caldarola
    Laetitia Teixeira
    Paolo Romanelli
    K. Desai
    Spyridon Gkalpakiotis
    Marco Romanelli
    Jensen Yeung
    Miguel Nogueira
    Andrea Chiricozzi
    American Journal of Clinical Dermatology, 2021, 22 : 567 - 579
12345